IP Library Granted Patent US 10,174,004
Granted Patent B2
US 10,174,004 · App. 14/768,784 · Granted Jan 8, 2019

Production method of pyridazinone compounds

Inventors: Naohiro Fukuda (Osaka, JP); Tomomi Ikemoto (Osaka, JP)
Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
C07D403/04C07D231/12C07D403/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,174,004
App. No.
14/768,784
Granted
Jan 8, 2019
Kind
B2
Abstract

The present invention provides an industrially advantageous method of producing a pyridazinone compound. The present invention relates to the following method of producing a pyridazinone compound: Formula (II), (IIIa), (IV) or (IV″), Formula (IIIb), (Vb) or (V″b), Formula (VI), (I) or (I″), wherein each symbol is as described in the specification.

Claims (32)

1. A method of producing a compound represented by the formula (I) or formula (I′):

wherein

R 1 is

(i) a C 6-14 aryl group,

(ii) —OR 8 wherein R 8 is a C 1-10 alkyl group or a C 6-14 aryl group, or

(iii) —SR 8 wherein R 8 is a C 6-14 aryl group,

R 2 is a hydrogen atom or a C 1-6 alkyl group,

Ring A is benzene substituted by 5- or 6-membered monocyclic aromatic heterocyclic group(s), and optionally further optionally substituted by 1 to 5 halogen atoms, and

R 7 is phenyl,

or a mixture thereof or a salt thereof, which comprises

step (1): a step of reacting a compound represented by the formula (II):

wherein each symbol is as defined above,

or a salt thereof, with a compound represented by the formula (Ma):

wherein

R 3a , R 4a , R 5a and R 6a are each independently a C 1-6 alkyl group,

or a salt thereof, to give a compound represented by the formula (IV) or formula (IV′):

wherein each symbol is as defined above,

or a mixture thereof or a salt thereof;

step (2): a step of reacting the compound represented by the formula (IV) or formula (IV′) or a mixture thereof or a salt thereof with a compound represented by the formula (IIIb):

wherein

R 3b , R 4b , R 5b and R 6b are each independently a C 1-6 alkyl group,

or a salt thereof, to give a compound represented by the formula (Vb) or formula (V′b):

wherein each symbol is as defined above,

or a mixture thereof or a salt thereof; and

step (3): a step of reacting the compound represented by formula (Vb) or formula (V′b) or a mixture thereof or a salt thereof, with a compound represented by the formula (VI):

R 7 NH—NH 2   (VI)

wherein each symbol is as defined above,

or a salt thereof.

2. The method of claim 1 , wherein the compound represented by the obtained formula (IV) or formula (IV′) or a mixture thereof or a salt thereof obtained in step (1) is subjected to step (2) without isolation.

3. The method of claim 1 , wherein R 1 is methoxy, and R 2 is a hydrogen atom.

4. The method of claim 1 , wherein Ring A is 4-(pyrazol-1-yl)-2-fluorobenzene, and R 7 is phenyl.

5. The method of claim 1 , wherein R 1 is methoxy, R 2 is a hydrogen atom, Ring A is 4-(pyrazol-1-yl)-2-fluorobenzene, and R 7 is phenyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2026
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 075778/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2015
From: FUKUDA, NAOHIRO; IKEMOTO, TOMOMI
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 036687/0969 →
Priority Claims (1)
JP 2013-032326 · Feb 21, 2013 · national
Continuity (1)
Related Publication 20160002209A1 · Jan 7, 2016